Results 321 to 330 of about 286,222 (357)
Some of the next articles are maybe not open access.
Current Opinion in Immunology, 2002
Increasingly, data from distinct experimental systems show that immunity can be activated to prevent tumors. The rationale for prevention is strong because, in that setting, one deals with an immune system that is neither impaired by tumor- and treatment-induced suppression nor tolerant to tumor-associated antigens that have been encountered in the ...
Olivera J, Finn, Guido, Forni
openaire +2 more sources
Increasingly, data from distinct experimental systems show that immunity can be activated to prevent tumors. The rationale for prevention is strong because, in that setting, one deals with an immune system that is neither impaired by tumor- and treatment-induced suppression nor tolerant to tumor-associated antigens that have been encountered in the ...
Olivera J, Finn, Guido, Forni
openaire +2 more sources
Expert Opinion on Biological Therapy, 2010
Personalized medicine has extended to management of cancer and implies prescription of specific therapeutics best suited for an individual patient and the type of tumor. These principles have been applied to cancer vaccines.Various cancer vaccines that can be personalized. Tumor-derived vaccines have been used and active immunotherapy based on antigens
openaire +2 more sources
Personalized medicine has extended to management of cancer and implies prescription of specific therapeutics best suited for an individual patient and the type of tumor. These principles have been applied to cancer vaccines.Various cancer vaccines that can be personalized. Tumor-derived vaccines have been used and active immunotherapy based on antigens
openaire +2 more sources
Expert Opinion on Therapeutic Patents, 2001
The intellectual property literature concerning novel cancer vaccine strategies for the period of 1998 and 2000 is reviewed. Nearly 400 citations have been identified and the majority of the citations described herein involve the identification of new tumour associated antigens and novel strategies of cancer vaccine formulations. Significant progresses
openaire +2 more sources
The intellectual property literature concerning novel cancer vaccine strategies for the period of 1998 and 2000 is reviewed. Nearly 400 citations have been identified and the majority of the citations described herein involve the identification of new tumour associated antigens and novel strategies of cancer vaccine formulations. Significant progresses
openaire +2 more sources
Current Opinion in Immunology, 2006
The immunological bases of current approaches to therapeutic cancer vaccination (or 'vacci-treatment') have been established for a decade or longer. The new developments lie mostly in the lessons learnt from clinical testing of these approaches. Three lessons are particularly worthy of note.
openaire +2 more sources
The immunological bases of current approaches to therapeutic cancer vaccination (or 'vacci-treatment') have been established for a decade or longer. The new developments lie mostly in the lessons learnt from clinical testing of these approaches. Three lessons are particularly worthy of note.
openaire +2 more sources
Advanced Drug Delivery Reviews, 2019
Immunotherapy is revolutionizing the treatment of cancer, and the current immunotherapeutics have remarkably improved the outcomes for some cancer patients. However, we still need answers for patients with immunologically cold tumors that do not benefit from the current immunotherapy treatments.
Yoosoo, Yang +4 more
openaire +2 more sources
Immunotherapy is revolutionizing the treatment of cancer, and the current immunotherapeutics have remarkably improved the outcomes for some cancer patients. However, we still need answers for patients with immunologically cold tumors that do not benefit from the current immunotherapy treatments.
Yoosoo, Yang +4 more
openaire +2 more sources
Expert Opinion on Investigational Drugs, 1998
A new era involving the evaluation of recombinant cancer vaccines has begun with the concurrent emergence of insights and technologies in the fields of molecular biology and immunology. These advances include: The identification and cloning of an array of genes associated with the neoplastic process, such as oncogenes, suppressor genes, genes encoding ...
J, Schlom +6 more
openaire +2 more sources
A new era involving the evaluation of recombinant cancer vaccines has begun with the concurrent emergence of insights and technologies in the fields of molecular biology and immunology. These advances include: The identification and cloning of an array of genes associated with the neoplastic process, such as oncogenes, suppressor genes, genes encoding ...
J, Schlom +6 more
openaire +2 more sources
Journal of Immunotherapy, 1993
Immune T cells recognize peptide antigens presented to them within self-MHC molecules. Thus auto-tumor reactive lymphocyte populations can be generated. Antigenic expression can be modified and intensified and reactive lymphocyte populations can be expanded.
J, Sinkovics +2 more
openaire +2 more sources
Immune T cells recognize peptide antigens presented to them within self-MHC molecules. Thus auto-tumor reactive lymphocyte populations can be generated. Antigenic expression can be modified and intensified and reactive lymphocyte populations can be expanded.
J, Sinkovics +2 more
openaire +2 more sources
2016
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Cancer is one of the major leading death causes of diseases. Prevention and treatment of cancer is an important way to decrease the incidence of tumorigenesis and prolong patients' lives. Subversive achievements on cancer immunotherapy have recently been paid much attention after many failures in basic and clinical researches. Based on deep analysis of
Zhenlong, Ye +3 more
openaire +2 more sources
Journal of Pediatric and Adolescent Gynecology, 2006
Major advances in the prevention of cervical cancer have been made this year. On average there are about 9710 new cases of cervical cancer in the United States each year and 3700 deaths attributed to it. The lethality of cervical cancer is even greater worldwide where it is the second most common cancer in women causing over 470000 new cases each year ...
openaire +2 more sources
Major advances in the prevention of cervical cancer have been made this year. On average there are about 9710 new cases of cervical cancer in the United States each year and 3700 deaths attributed to it. The lethality of cervical cancer is even greater worldwide where it is the second most common cancer in women causing over 470000 new cases each year ...
openaire +2 more sources
2016
mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. The most straightforward use of mRNA vaccines in oncologic settings is the immunization of patients with mRNA vaccines encoding tumor-associated antigens ...
Katja, Fiedler +4 more
openaire +2 more sources
mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. The most straightforward use of mRNA vaccines in oncologic settings is the immunization of patients with mRNA vaccines encoding tumor-associated antigens ...
Katja, Fiedler +4 more
openaire +2 more sources